The domestic pharmaceutical industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities and continuation of tax concessions on various drugs in the upcoming Union Budget. The industry is also seeking simplification of various processes in order to enhance ease of doing business for the private sector companies. "An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Policy 2017 along with a separate allocation for the bio-pharmaceutical sector R&D is imperative," Organisation of Pharmaceutical Producers of India (OPPI) President S Sridhar told PTI. The industry saw significant momentum over the past year, especially in ensuring access to COVID-19 vaccines and medicines and this year's Budget will be crucial to accelerate sectoral growth and access to innovative health solutions across various diseases and not COVID ...
Healthcare sector is likely to receive the highest priority in the upcoming Union Budget 2022-23 on account of continuing challenges posed by COVID-19
Karnataka has effectively leveraged technology in COVID battle and so far about 2.5 lakh healthcare and frontline staff have been trained through online platforms
The applicant devised a plan for providing health care services for the next 20 years for which a lump-sum amount, say, Rs 10 lakh, will be charged
United Health Interface is a set of protocols that is going to create a language of health service delivery
There are 55 functioning PHCs in the state's rural areas, and four in urban areas
Health index needs a rejig
Analysis shows that UP did not show any gains in most parameters concerning health outcomes
The first of the year-ender series takes a dive into the health care crisis that India faced this year and what's in store as 2022 rings in
While doctors and patients went online to mitigate infection risk, pharma companies too adopted digital tools rapidly for customer engagement, development of multiple delivery models and R&D
Investment company to focus on media, education & healthcare
Zydus to keep a laboratory product ready based on the new variant
The health-care giant will split off its consumer division in 18 to 24 months, the company said in a statement
Under this partnership, eGov will facilitate access to administrative data that can be used by J-PAL affiliated researchers to design and evaluate policy programs
The announcements, which include a raft of smaller spending decisions, follows news of £6.9 billion for regional transport projects ahead of a major review of government spending
Healthcare industry leaders on Thursday hailed the country surpassing the 100-crore COVID-19 vaccination mark and termed it as a historic moment. Serum Institute of India (SII) CEO Adar Poonawalla, whose company is one of the major providers of COVID-19 vaccine in the country, congratulated Prime Minister Narendra Modi, various ministries and healthcare workers for achieving the milestone. "My heartiest congratulations, Shri @narendramodi Ji, as India crosses 1 billion doses of COVID vaccine inoculations today under your exemplary leadership. I also congratulate all the GOI ministries, agencies, & healthcare workers for their relentless efforts during this pandemic," he tweeted. Bharat Biotech Joint Managing Director Suchitra Ella, while tagging PM Modi, Health Minister Mansukh Mandaviya and others, tweeted: "Congratulations India. Thanx a Billion! A global feat achieved overcoming Covid Challenges Collaborations Commitment Confidence Courage Compassion in PUBLIC HEALTH ...
The government's National Telemedicine Service, eSanjeevani, has clocked 14 million consultations so far, with Andhra Pradesh, Karnataka and Tamil Nadu among the 10 states
Special focus is being provided to the states with an inadequately trained workforce, the minister said
Metropolis Healthcare said its board approved the acquisition of Hitech Diagnostic Centre and its arm Centralab Healthcare Services in a combination of cash and equity shares deal.
HCL Technologies on Monday said it has expanded its strategic partnership with Google Cloud to jointly launch healthcare and life sciences solutions for customers